Literature DB >> 20691711

An "Omics" based survey of human colon cancer.

Prashant R Nambiar1, Rishi R Gupta, Vikas Misra.   

Abstract

Despite an increased understanding of the molecular pathogenesis of colorectal cancer (CRC) during the past two decades, reliable and robust biomarkers to enable screening, surveillance, and primary prevention of this disease are lacking. CRC diagnosis and therapy remain dependent upon descriptive classification and staging systems, based primarily on morphology and histology. The traditional approach of understanding complex biological systems by studying smaller, discrete units of the whole system has been less fruitful for understanding complex diseases. The implicit assumption of traditional methods, that a single or even only a few factors, play a dominant role in a complex disease might be inadequate when studying multifactorial diseases such as cancer. The burgeoning field of systems biology adopts a holistic approach, wherein the integration of individual parts of the system is sought. The cornerstone of a systems biology approach has been the development of a variety of high-throughput "omics" sciences, including genomics, transcriptomics, proteomics, and metabolomics. This review will focus on the "omics" literature in the field of sporadic human CRC and present examples of how a systems approach has been extremely useful in understanding concepts that would have been difficult to develop using traditional methods. 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20691711     DOI: 10.1016/j.mrfmmm.2010.07.008

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  29 in total

Review 1.  Diagnosis of gastroenterological diseases by metabolome analysis using gas chromatography-mass spectrometry.

Authors:  Masaru Yoshida; Naoya Hatano; Shin Nishiumi; Yasuhiro Irino; Yoshihiro Izumi; Tadaomi Takenawa; Takeshi Azuma
Journal:  J Gastroenterol       Date:  2011-11-02       Impact factor: 7.527

Review 2.  Therapeutic cancer vaccines and translating vaccinomics science to the global health clinic: emerging applications toward proof of concept.

Authors:  Megan M O'Meara; Mary L Disis
Journal:  OMICS       Date:  2011-07-06

3.  Integrative X-ray Structure and Molecular Modeling for the Rationalization of Procaspase-8 Inhibitor Potency and Selectivity.

Authors:  Janice H Xu; Jerome Eberhardt; Brianna Hill-Payne; Gonzalo E González-Páez; José Omar Castellón; Benjamin F Cravatt; Stefano Forli; Dennis W Wolan; Keriann M Backus
Journal:  ACS Chem Biol       Date:  2020-01-23       Impact factor: 5.100

4.  Profiling the immune stromal interface in breast cancer and its potential for clinical impact.

Authors:  Sheeba Irshad; Anita Grigoriadis; Katherine Lawler; Tony Ng; Andrew Tutt
Journal:  Breast Care (Basel)       Date:  2012-08       Impact factor: 2.860

5.  Metabolomics method to comprehensively analyze amino acids in different domains.

Authors:  Haiwei Gu; Jianhai Du; Fausto Carnevale Neto; Patrick A Carroll; Sally J Turner; E Gabriela Chiorean; Robert N Eisenman; Daniel Raftery
Journal:  Analyst       Date:  2015-02-20       Impact factor: 4.616

6.  Proteomics, genomics, and molecular biology in the personalized treatment of colorectal cancer.

Authors:  John M Carethers
Journal:  J Gastrointest Surg       Date:  2012-07-04       Impact factor: 3.452

7.  Identification of key candidate genes and pathways associated with colorectal aberrant crypt foci-to-adenoma-to-carcinoma progression.

Authors:  Setareh Fayazfar; Afsaneh Arefi Oskouie; Akram Safaei; Hakimeh Zali; Ehsan Nazemalhosseini Mojarad
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2021

8.  Proteomic profile identifies dysregulated pathways in Cornelia de Lange syndrome cells with distinct mutations in SMC1A and SMC3 genes.

Authors:  Anna Gimigliano; Linda Mannini; Laura Bianchi; Michele Puglia; Matthew A Deardorff; Stefania Menga; Ian D Krantz; Antonio Musio; Luca Bini
Journal:  J Proteome Res       Date:  2012-11-05       Impact factor: 4.466

Review 9.  Systems-level biomarkers identification and drug repositioning in colorectal cancer.

Authors:  Hande Beklen; Esra Yildirim; Medi Kori; Beste Turanli; Kazim Yalcin Arga
Journal:  World J Gastrointest Oncol       Date:  2021-07-15

10.  Identifying molecular targets of lifestyle modifications in colon cancer prevention.

Authors:  Molly M Derry; Komal Raina; Chapla Agarwal; Rajesh Agarwal
Journal:  Front Oncol       Date:  2013-05-14       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.